INAPPROPRIATE USAGE OF INTRAVENOUS PROTON PUMP INHIBITORS AND ASSOCIATED FACTORS IN A HIGH COMPLEXITY HOSPITAL IN BRAZIL
Open Access
- 1 March 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (1) , 32-38
Abstract
BACKGROUND: Intravenous (IV) use of proton pump inhibitors (PPIs) is advised only in cases of suspected upper gastrointestinal bleeding (UGIB) or impossibility of receiving oral medication, although there has been a persistent practice of their inappropriate use in health institutions. OBJECTIVE: The purpose of our study was to measure the inappropriate use of IV PPIs in a high complexity hospital in Brazil and to estimate its costs. METHODS: Retrospective study of 333 patients who received IV omeprazole between July and December of 2018 in a high complexity hospital in Brazil. RESULTS: IV omeprazole was found to be appropriately prescribed in only 23.4% patient reports. This medication was administered mainly in cases of suspected UGIB (19.1%) and stress ulcer prophylaxis in patients with high risk of UGIB unable to receive medication orally (18.7%). It was observed a statistically significant association between adequate prescription and stress ulcer prophylaxis in patients with high risk of UGIB unable to receive medication orally; patient nil per os with valid indication for PPIs usage; prescription by intensive care unit doctors; prescription by emergency room doctors; intensive care unit admission; evolution to death; sepsis; and traumatic brain injury (P<0.05). On the other hand, inadequate prescription had a statistically significant association with surgical ward prescription and non-evolution to death (P<0.05). The estimated cost of the vials prescribed inadequately was US$1696. CONCLUSION: There was a high number of inappropriate IV omeprazole prescriptions in the studied hospital, entailing greater costs to the institution and unnecessary risks.Keywords
This publication has 17 references indexed in Scilit:
- Stress Ulcer ProphylaxisCritical Care Medicine, 2016
- Intermittent vs Continuous Proton Pump Inhibitor Therapy for High-Risk Bleeding UlcersJAMA Internal Medicine, 2014
- Management of Patients With Ulcer BleedingAmerican Journal of Gastroenterology, 2012
- Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factorsQJM: An International Journal of Medicine, 2010
- International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal BleedingAnnals of Internal Medicine, 2010
- Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: A prospective observational studySaudi Journal of Gastroenterology, 2010
- Pharmacology of proton pump inhibitorsCurrent Gastroenterology Reports, 2008
- Review article: the clinical pharmacology of proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2006
- Inappropriate Use of Intravenous Pantoprazole: Extent of the Problem and Successful SolutionsClinical Gastroenterology and Hepatology, 2005
- Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic UlcersNew England Journal of Medicine, 2000